Oct 30 (Reuters) - Valeant Pharmaceuticals International Inc (N:VRX) VRX.TO :
* To terminate relationship with philidor
* Says severing all ties with philidor rx services, llc
* Philidor informed co that it will shut down operations as soon as possible,
consistent with applicable laws
* Says intends to develop a plan to ensure patients' access to drugs is
minimally disrupted
* Newest allegations about activities at philidor raise additional questions"
about co's business practices
* Lost confidence in philidor's ability to continue to operate in a manner that
is acceptable to Valeant"
* Informed philidor that to the extent that managed care plans will no longer
reimburse prescriptions in process
* To continue to explore relationships with full range of pharmacies
* Says in the third quarter 2015, philidor represented 6.8% of total Valeant
revenue
* Pharma's CEO says allegations have also led patients, doctors to question
co's integrity, "and for that i take complete responsibility"
* Source text for Eikon ID:nPn2XrdlQ
* Further company coverage VRX.TO